Clinical Trial

Performance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 20, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
Spectral CT is a rapidly expanding imaging modality that allows a reduction in iodine dose and irradiation compared to conventional scanning. It uses the difference in attenuation of the material according to the two different energy levels of the incident x-ray beams. The dual-energy scanner has a wide range of clinical applications, particularly in abdominal imaging.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-29; most recent amendment 2024-09-19.
Trial Details
NCT Number NCT06024837
Lead Sponsor Centre Hospitalier Universitaire de Saint Etienne
Conditions Colo-rectal Cancer
Enrollment 100 participants
Start Date 2023-06-07
Primary Completion 2025-01 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-09-20